Publication | Open Access

Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models

Cancer ImmunosurveillanceMurine Cancer ModelsImmunologyImmune Checkpoint InhibitorEnhanced Checkpoint BlockadeImmunotherapyMedicineCell BiologyCell SignalingAdenosine A2a ReceptorCancer Research